Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Esophageal Cancer: A Phase II Study of Paclitaxel, Carboplatin and 5-Fluorouracil With Simultaneous Radiotherapy Followed by Surgical Resection

NCT00006472 is registered in ClinicalTrials.gov with Medstar Health Research Institute as lead sponsor.

NCT NCT00006472
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00006472 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Esophageal Cancer: A Phase II Study of Paclitaxel, Carboplatin and 5-Fluorouracil With Simultaneous Radiotherapy Followed by Surgical Resection
Lead sponsor
Medstar Health Research Institute
Phase
Phase 2
Overall status
Terminated
Start date
January 31, 2000
Completion date
September 10, 2002
Enrollment
4 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal cancer